This caught your eye...
Preview text: Ready to invest in your hair?
No image available for this email.
- Subject
- This caught your eye...
- Preview text
- Ready to invest in your hair?
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Thu Jul 9, 2026, 12:09 AM ET
- Size
- 48 KB
- Images
- 10
- Links
- 12, 1 of them buttons
- Subject length
- 23 characters
Against Salt Grooming's usual
Sent in the 12 AM hour, which holds 4% of its emails; 19% arrive in the 5 AM hour. The subject is 23 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Salt Grooming <[email protected]>
- Subject
- This caught your eye...
- Date
- Thu, 09 Jul 2026 04:09:39 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-54
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from o1398.shared.klaviyomail.com [149.72.95.9] by our receiving server with ESMTPS
- by recvd-…-tfjc2 with SMTP
- from (unnamed) by geopod-ismtpd-54 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Flow, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| Jul 11, 2026 12:11 AM | Low stock alert [10% OFF inside] | |
| Jul 10, 2026 5:30 AM | Even good genes have their limits. | |
| Jul 10, 2026 12:10 AM | Your hair deserves better... | |
| Jul 9, 2026 12:09 AM | This caught your eye... (this email) | |
| Jul 8, 2026 3:30 PM | 2 minutes. Free hair prescription | |
| Jul 8, 2026 12:08 AM | Selling fast. Secure your product | |
| Jul 6, 2026 4:30 AM | Heat’s not the problem |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM







